| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other (expense) income, net | -1,448 | 441 | 667 | 32 |
| Net loss attributable to common stockholders | -15,099 | -12,587 | -12,433 | -13,484 |
| Comprehensive loss | -15,099 | -12,587 | -12,433 | -13,484 |
| Net loss per share attributable to common stockholders, basic, (in dollars per share) | -0.55 | -0.62 | -0.62 | -24.19 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.55 | -0.62 | -0.62 | -24.19 |
| Weighted-average common shares outstanding, diluted (in shares) | 27,274,721 | 20,159,666 | 20,152,872 | 557,437 |
| Weighted-average shares of common stock outstanding, basic (in shares) | 27,274,721 | 20,159,666 | 20,152,872 | 557,437 |
Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP)